We are live on !
Find out more
Wealth Effects Portfolio holdings
AUM
$370M
Turnover
11.85%
1-Year Est. Return
63.53%
This Fund
S&P 500
This Quarter Est. Return
+10.63%
1 Year Est. Return
+63.53%
3 Year Est. Return
+235.33%
5 Year Est. Return
+296.22%
10 Year Est. Return
–
AUM
$175M
AUM Growth
+$11.7M
(+7.1%)
Cap. Flow
+$906K
Cap. Flow % of AUM
Cap. Flow %
0.52%
Top 10 Holdings %
Top 10 Hldgs %
37.76%
Holding
209
New
26
Increased
49
Reduced
95
Closed
18
Avg Time Held
0.8
years
Top 10 Avg Time Held
0.8
years
Top 20 Avg Time Held
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$4.92M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$2M |
| 3 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$1.7M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$1.48M |
| 5 |
Vanguard Morningstar Growth ETF
VUG
|
+$1.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.62M |
| 2 |
Steris
STE
|
+$1.75M |
| 3 |
Pfizer
PFE
|
+$970K |
| 4 |
Roku
ROKU
|
+$840K |
| 5 |
iShares 0-5 Year TIPS Bond ETF
STIP
|
+$790K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.42% |
| 2 | Miscellaneous | 22.03% |
| 3 | Technology | 17.53% |
| 4 | Financials | 8.13% |
| 5 | Industrials | 5.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
AVDL
1
DELISTED
Avadel Pharmaceuticals
AVDL
| $18M | 10.28% |
2,514,905
-79,855
| -3% | -$560K |
2021 Q4
4 quarters
|
|
|
2
Apple
AAPL
$5.18T
| $12.4M | 7.1% |
95,703
-18,344
| -16% | -$2.62M |
2021 Q4
4 quarters
|
|
3
Arrowhead Research
ARWR
$6.75B
| $6.31M | 3.6% |
155,620
-1,000
| -0.6% | -$33.1K |
2021 Q4
4 quarters
|
|
4
Microsoft
MSFT
$3.89T
| $5.07M | 2.9% |
21,156
-357
| -2% | -$85.7K |
2021 Q4
4 quarters
|
|
5
Amazon
AMZN
$2.88T
| $4.88M | 2.79% |
58,095
-1,506
| -3% | -$149K |
2021 Q4
4 quarters
|
|
|
6
Vanguard Morningstar Total Stock Market ETF
VTI
$689B
| $4.88M | 2.78% |
+25,507
| New | +$4.92M |
2022 Q4
0 quarters
|
|
7
JPMorgan Chase
JPM
$919B
| $4.28M | 2.44% |
31,909
-413
| -1% | -$52.3K |
2021 Q4
4 quarters
|
|
8
NVIDIA
NVDA
$3.93T
| $3.71M | 2.12% |
253,670
-13,460
| -5% | -$197K |
2021 Q4
4 quarters
|
|
9
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.56B
| $3.6M | 2.05% |
75,896
-3,502
| -4% | -$166K |
2021 Q4
4 quarters
|
|
10
Alphabet (Google) Class A
GOOGL
$3.64T
| $2.98M | 1.7% |
33,760
-1,925
| -5% | -$183K |
2021 Q4
4 quarters
|
|
|
11
Pfizer
PFE
$165B
| $2.76M | 1.58% |
53,893
-20,233
| -27% | -$970K |
2021 Q4
4 quarters
|
|
12
Chevron
CVX
$429B
| $2.49M | 1.42% |
13,889
-558
| -4% | -$97.4K |
2021 Q4
4 quarters
|
|
13
AbbVie
ABBV
$521B
| $2.34M | 1.34% |
14,509
-29
| -0.2% | -$4.45K |
2021 Q4
4 quarters
|
|
14
Trade Desk
TTD
$7.41B
| $2.21M | 1.26% |
49,335
-5,070
| -9% | -$257K |
2021 Q4
4 quarters
|
|
15
Blackstone
BX
$95B
| $2.19M | 1.25% |
29,493
-8,179
| -22% | -$706K |
2021 Q4
4 quarters
|
|
16
Beyond Air
XAIR
$2.1M
| $2.12M | 1.21% |
815
+3
| +0.4% | +$7.68K |
2021 Q4
4 quarters
|
|
|
17
iShares Core S&P 500 ETF
IVV
$875B
| $1.99M | 1.14% |
+5,186
| New | +$2M |
2022 Q4
0 quarters
|
|
18
Johnson & Johnson
JNJ
$688B
| $1.87M | 1.07% |
10,600
+292
| +3% | +$50.4K |
2021 Q4
4 quarters
|
|
19
Merck
MRK
$364B
| $1.81M | 1.03% |
16,329
-171
| -1% | -$17.5K |
2021 Q4
4 quarters
|
|
20
UnitedHealth
UNH
$365B
| $1.74M | 0.99% |
3,283
-300
| -8% | -$159K |
2021 Q4
4 quarters
|
|
|
21
iShares Core S&P Total US Stock Market ETF
ITOT
$95.5B
| $1.69M | 0.96% |
+19,924
| New | +$1.7M |
2022 Q4
0 quarters
|
|
22
3D Systems Corp
DDD
$255M
| $1.67M | 0.95% |
225,275
-34,000
| -13% | -$298K |
2021 Q4
4 quarters
|
|
23
CVS Health
CVS
$114B
| $1.63M | 0.93% |
17,507
-3,320
| -16% | -$320K |
2021 Q4
4 quarters
|
|
24
Global X NASDAQ-100 Covered Call ETF
QYLD
$8.12B
| $1.52M | 0.87% |
95,377
-5,478
| -5% | -$88.5K |
2021 Q4
4 quarters
|
|
25
General Mills
GIS
$18.4B
| $1.51M | 0.86% |
18,033
-266
| -1% | -$21.7K |
2021 Q4
4 quarters
|
|
Similar funds
BC
Wealth Effects's Q4 2022 Portfolio in Review
As of Q4 2022, Wealth Effects held 209 positions worth $175M, up 7.1% from $164M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Wealth Effects's Q4 2022 filing shows 26 new, 49 increased, 95 reduced and 18 closed positions. Its largest new stake was Vanguard Morningstar Total Stock Market ETF: 25,507 shares worth $4.88M. The largest sale was Apple, an estimated $2.62M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 26% a quarter earlier, followed by Miscellaneous and Technology.
- Wealth Effects's largest Q4 2022 buy was Vanguard Morningstar Total Stock Market ETF: 25,507 shares worth $4.88M.
- Wealth Effects added most to Vanguard Short-Term Corporate Bond ETF in Q4 2022, an estimated $670K increase.
- Wealth Effects's biggest Q4 2022 reduction was Apple, cutting an estimated $2.62M.
- Wealth Effects fully exited Steris in Q4 2022, selling an estimated $1.75M.
- Wealth Effects's ten largest holdings make up 38% of its $175M portfolio in Q4 2022.
- Wealth Effects opened 26 new positions and closed 18 in Q4 2022.
- Wealth Effects's portfolio value rose 7.1% quarter-over-quarter to $175M.
Based on Wealth Effects's 13F filing for Q4 2022, filed 2 Feb 2023.